Fundz

Who to call at Syndax Pharmaceuticals, and when

Fundz watches for the moments Syndax Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Syndax Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Syndax Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Syndax Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Syndax Pharmaceuticals Partners with World Orphan Drug Alliance to Expand Access to Revuforj® Globally.

Jan 07, 2026

Contract Type

partnership

New YorkBiotechnologyHealthcarePharmaceuticalBiopharma

Description

Syndax Pharmaceuticals and the World Orphan Drug Alliance have announced a collaboration to enhance access to Revuforj® via a Managed Access Program in regions where the drug is not commercially available. This initiative aims to provide opportunities for physicians and patients in areas spanning Eurasia, Europe, Israel, the Middle East, Latin America, and Africa.

Company Information

Company

Syndax Pharmaceuticals

Location

New York, New York, United States

About

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment.

Related People

Steven
Likely contact at this company
••••••••@••••••••

See Steven's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Syndax Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Syndax Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.